Marco G. Paggi

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Chlorpromazine activates cGAS-STING signaling and reprograms the immune response in glioblastoma.

Chlorpromazine activates cGAS-STING signaling and reprograms the immune response in glioblastoma.

Journal: Frontiers in immunology

Published: November 10, 2025

Integrated screening for small molecules interfering with PKM2: a drug repurposing strategy against glioblastoma.

Integrated screening for small molecules interfering with PKM2: a drug repurposing strategy against glioblastoma.

Journal: Journal of translational medicine

Published: October 10, 2025

Glioblastoma metabolomics: uncovering biomarkers for diagnosis, prognosis and targeted therapy.

Glioblastoma metabolomics: uncovering biomarkers for diagnosis, prognosis and targeted therapy.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 19, 2025

Chlorpromazine overcomes temozolomide resistance in glioblastoma by inhibiting Cx43 and essential DNA repair pathways.

Chlorpromazine overcomes temozolomide resistance in glioblastoma by inhibiting Cx43 and essential DNA repair pathways.

Journal: Journal of translational medicine

Published: May 06, 2024

Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial.

Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial.

Journal: Frontiers in oncology

Published: October 12, 2023

Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2.

Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2.

Journal: Cell death & disease

Published: July 20, 2023

Molecular Biology in Glioblastoma Multiforme Treatment.

Molecular Biology in Glioblastoma Multiforme Treatment.

Journal: Cells

Published: May 30, 2022

Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma.

Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma.

Journal: Cells

Published: December 07, 2021

Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma.

Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma.

Journal: Molecular genetics and genomics : MGG

Published: September 23, 2021

Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response.

Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 16, 2021

Physical Interaction between HPV16E7 and the Actin-Binding Protein Gelsolin Regulates Epithelial-Mesenchymal Transition via HIPPO-YAP Axis.

Physical Interaction between HPV16E7 and the Actin-Binding Protein Gelsolin Regulates Epithelial-Mesenchymal Transition via HIPPO-YAP Axis.

Journal: Cancers

Published: December 29, 2020

Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro.

Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro.

Journal: Frontiers in oncology

Published: November 30, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026